ロード中...
Augmentation of nab-paclitaxel chemotherapy response by mechanistically diverse antiangiogenic agents in preclinical gastric cancer models
Gastric adenocarcinoma (GAC) remains the third most common cause of cancer deaths worldwide. Systemic chemotherapy is commonly recommended as a fundamental treatment for metastatic GAC, however, standard treatment has not been established yet. Angiogenesis plays a crucial role in the progression and...
保存先:
| 出版年: | Mol Cancer Ther |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6215503/ https://ncbi.nlm.nih.gov/pubmed/30166402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-18-0489 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|